Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway

Front Pharmacol. 2023 Aug 17:14:1236892. doi: 10.3389/fphar.2023.1236892. eCollection 2023.

Ji Hu^{1

2}, Ru Chen^{1

2}, Jie An^{1

2

3}, Yilong Wang^{1

2

4}, Minglu Liang^{1

2}, Kai Huang^{1

2

5

6}

¹ Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Department of Cardiology, Handan First Hospital, Handan, China.
⁴ Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
⁵ Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Huazhong University of Science and Technology, Wuhan, China.
⁶ Hubei Clinical Research Center of Metabolic and Cardiovascular Disease, Huazhong University of Science and Technology, Wuhan, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.758962.].

Keywords: NF-κB pathway; acute lung injury; dauricine; endothelial dysfunction; inflammation.